|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of ABCB11 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of ABCB11 protein |
CTD |
PMID:12044520 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of ABCB1 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of ABCB1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of ABCC2 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of ABCC2 protein |
CTD |
PMID:12044520 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Actb |
actin, beta |
increases expression decreases expression |
ISO EXP |
Trinitrobenzenesulfonic Acid results in increased expression of ACTB mRNA Trinitrobenzenesulfonic Acid results in decreased expression of ACTB mRNA |
CTD |
PMID:12163651 PMID:17982090 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Adm2 |
adrenomedullin 2 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of ADM2 mRNA |
CTD |
PMID:21808981 |
|
NCBI chr 7:120,393,179...120,394,965
Ensembl chr 7:120,393,179...120,396,331
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
multiple interactions increases expression increases abundance |
EXP |
cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of AGER protein]; dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of AGER protein]; hesperetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of AGER protein]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of AGER protein] 2,4,6-trinitrobenzenesulfonic acid increases abundance of Ager protein in rat colon |
CTD RGD |
PMID:33412153 PMID:33522063 PMID:29572553 |
RGD:152995414 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Agr2 |
anterior gradient 2, protein disulphide isomerase family member |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of AGR2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in decreased susceptibility to Trinitrobenzenesulfonic Acid |
CTD |
PMID:21131560 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ak3 |
adenylate kinase 3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of AK3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Akap6 |
A-kinase anchoring protein 6 |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of AKAP6 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 6:70,184,101...70,624,369
Ensembl chr 6:70,184,175...70,619,738
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of AKAP9 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of AKR1C2 mRNA |
CTD |
PMID:25724174 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Alb |
albumin |
increases secretion |
EXP |
Trinitrobenzenesulfonic Acid results in increased secretion of ALB protein |
CTD |
PMID:23307618 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Alpi |
alkaline phosphatase, intestinal |
increases activity multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in increased activity of ALPI protein Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of ALPI protein] |
CTD |
PMID:15867298 |
|
NCBI chr 9:87,773,411...87,776,877
Ensembl chr 9:87,773,411...87,776,877
|
|
G |
Amy1 |
amylase alpha 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of AMY2A5 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:201,382,678...201,397,487
Ensembl chr 2:201,382,675...201,397,816
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of ANXA1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa8 |
annexin A8 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of ANXA8 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
|
|
G |
Apbb1ip |
amyloid beta precursor protein binding family B member 1 interacting protein |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of APBB1IP mRNA |
CTD |
PMID:17982090 |
|
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
|
|
G |
Apob |
apolipoprotein B |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of APOB mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of AQP3 mRNA |
CTD |
PMID:15140218 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Aqp4 |
aquaporin 4 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of AQP4 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Arfip1 |
ARF interacting protein 1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of ARFIP1 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 2:169,843,804...169,924,136
Ensembl chr 2:169,843,801...169,923,142
|
|
G |
Arg1 |
arginase 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of ARG1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arg2 |
arginase 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of ARG2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgap24 |
Rho GTPase activating protein 24 |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of ARHGAP24 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr14:6,800,624...7,183,877
Ensembl chr14:6,800,631...7,183,823
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARHGDIB mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Arl4d |
ARF like GTPase 4D |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of ARL4D mRNA |
CTD |
PMID:23537331 |
|
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
|
|
G |
Arrb1 |
arrestin, beta 1 |
multiple interactions increases expression |
EXP |
Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 mRNA]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 protein]; qingre zaoshi liangxue fang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 mRNA]; qingre zaoshi liangxue fang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 protein] Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 protein |
CTD |
PMID:24637189 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Atoh1 |
atonal bHLH transcription factor 1 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of ATOH1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 4:93,912,068...93,914,163
Ensembl chr 4:93,912,068...93,914,154
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of ATP2A2 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of ATP2A2 protein |
CTD |
PMID:17131044 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp4a |
ATPase H+/K+ transporting subunit alpha |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of ATP4A mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:85,961,607...85,974,972
Ensembl chr 1:85,961,708...85,974,844
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions increases expression |
EXP |
Losartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAK1 mRNA] |
CTD |
PMID:15502641 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of BASP1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP ISO |
dapagliflozin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAX protein]; Losartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAX mRNA]; Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAX protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAX protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAX mRNA] D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of BAX protein] Trinitrobenzenesulfonic Acid results in increased expression of BAX mRNA; Trinitrobenzenesulfonic Acid results in increased expression of BAX protein |
CTD |
PMID:15502641 PMID:22427801 PMID:24831514 PMID:31428839 PMID:33412153 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression increases expression decreases abundance |
EXP |
dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein]; Losartan promotes the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 mRNA]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 protein]; Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein]; qingre zaoshi liangxue fang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 mRNA]; qingre zaoshi liangxue fang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA] Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein Trinitrobenzenesulfonic Acid results in increased expression of BCL2 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of BCL2 protein 2,4,6-trinitrobenzenesulfonic acid decreases abundance of Bcl-2 protein in rat colon |
CTD RGD |
PMID:15502641 PMID:24637189 PMID:24831514 PMID:31428839 PMID:33412153 PMID:29572553 More...
|
RGD:152995414 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of BCL2A1B mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
multiple interactions increases expression |
ISO |
[Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein] promotes the reaction [BCL2L11 protein binds to MAPK9 protein]; D-JNKI-1 inhibits the reaction [[Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein] promotes the reaction [BCL2L11 protein binds to MAPK9 protein]]; D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of BCL2L11 protein] Trinitrobenzenesulfonic Acid results in increased expression of BCL2L11 protein |
CTD |
PMID:22427801 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL3 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
|
|
G |
Becn1 |
beclin 1 |
multiple interactions increases expression |
EXP |
dapagliflozin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BECN1 protein]; Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BECN1 protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BECN1 protein] |
CTD |
PMID:30503585 PMID:33412153 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of BGLAP protein |
CTD |
PMID:23747339 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Bgn |
biglycan |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of BGN mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BGN mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Bpnt2 |
3'(2'), 5'-bisphosphate nucleotidase 2 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of BPNT2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 5:17,775,684...17,802,570
Ensembl chr 5:17,772,608...17,802,570
|
|
G |
C1qb |
complement C1q B chain |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of C1QB mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C1qc |
complement C1q C chain |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of C1QC mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C3 |
complement C3 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of C3 mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C4b |
complement C4B |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of C4B mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of C4B mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
Cab39 |
calcium binding protein 39 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of CAB39 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr 9:86,463,095...86,524,545
Ensembl chr 9:86,463,095...86,524,544
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of CACNA1C mRNA; Trinitrobenzenesulfonic Acid results in increased expression of CACNA1C protein |
CTD |
PMID:23537331 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna1e |
calcium voltage-gated channel subunit alpha1 E |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of CACNA1E mRNA; Trinitrobenzenesulfonic Acid results in increased expression of CACNA1E protein |
CTD |
PMID:23537331 |
|
NCBI chr13:66,574,659...67,063,443
Ensembl chr13:66,581,920...66,894,450
|
|
G |
Calcb |
calcitonin-related polypeptide, beta |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of CALCB mRNA |
CTD |
PMID:21808981 |
|
NCBI chr 1:168,965,383...168,970,259
Ensembl chr 1:168,966,465...168,970,125
|
|
G |
Calcrl |
calcitonin receptor like receptor |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of CALCRL mRNA |
CTD |
PMID:21808981 |
|
NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of CAMK2B mRNA |
CTD |
PMID:23537331 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Capg |
capping actin protein, gelsolin like |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CAPG mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Capn1 |
calpain 1 |
multiple interactions increases expression |
EXP |
Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CAPN1 protein] |
CTD |
PMID:30503585 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Car3 |
carbonic anhydrase 3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CAR3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Casp1 |
caspase 1 |
multiple interactions increases expression |
EXP |
bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of and results in increased cleavage of CASP1 protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP1 protein modified form]; Trinitrobenzenesulfonic Acid results in increased expression of and results in increased cleavage of CASP1 protein |
CTD |
PMID:30365937 PMID:30503585 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
multiple interactions increases cleavage |
EXP |
Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP12 protein modified form]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased cleavage of CASP12 protein] |
CTD |
PMID:30503585 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
ISO EXP |
D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of CASP3 protein]; Trinitrobenzenesulfonic Acid results in increased cleavage of and results in increased activity of CASP3 protein dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of CASP3 protein]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP3 protein]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of CASP3 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP3 protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP3 protein modified form]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of and results in increased activity of CASP3 protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP3 mRNA]; Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of CASP3 protein; Trinitrobenzenesulfonic Acid results in increased expression of and results in increased activity of CASP3 protein Trinitrobenzenesulfonic Acid results in increased expression of CASP3 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of CASP3 protein; Trinitrobenzenesulfonic Acid results in increased expression of CASP3 protein modified form |
CTD |
PMID:22427801 PMID:24831514 PMID:26165751 PMID:30503585 PMID:33412153 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
multiple interactions |
EXP |
bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of and results in increased cleavage of CASP4 protein]; Trinitrobenzenesulfonic Acid results in increased expression of and results in increased cleavage of CASP4 protein |
CTD |
PMID:30365937 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp8 |
caspase 8 |
multiple interactions decreases expression |
EXP |
Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CASP8 protein modified form] |
CTD |
PMID:30503585 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases expression multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of CASP9 protein modified form Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP9 protein modified form]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP9 protein modified form] |
CTD |
PMID:30503585 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases expression decreases expression multiple interactions |
ISO EXP |
Trinitrobenzenesulfonic Acid results in increased expression of CAT mRNA Trinitrobenzenesulfonic Acid results in decreased expression of CAT mRNA Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CAT mRNA] |
CTD |
PMID:17982090 PMID:30503585 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression multiple interactions increases secretion |
ISO EXP |
Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of CCL2 protein Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA]; Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA] icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 protein] Trinitrobenzenesulfonic Acid results in increased secretion of CCL2 protein |
CTD |
PMID:17449585 PMID:17982090 PMID:23307618 PMID:23596210 PMID:30503585 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions increases expression |
ISO |
[cholan-2,3,24-tryl-2,3,24-trisulfate binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL3 protein]; [rifaximin binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL3 protein]; cholan-2,3,24-tryl-2,3,24-trisulfate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL3 protein]; icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL3 protein]; rifaximin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL3 protein] |
CTD |
PMID:21599020 PMID:23596210 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
multiple interactions increases expression |
ISO |
icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL4 protein] |
CTD |
PMID:23596210 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CCL7 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions increases expression |
ISO |
stattic inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCN2 mRNA] |
CTD |
PMID:25740948 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn4 |
cellular communication network factor 4 |
multiple interactions increases expression decreases expression |
ISO EXP |
NOS2 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCN4 mRNA] Trinitrobenzenesulfonic Acid results in decreased expression of CCN4 mRNA |
CTD |
PMID:19238344 PMID:23537331 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CCNB1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CCR2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CCR5 mRNA |
CTD |
PMID:15973123 PMID:17982090 |
|
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd14 |
CD14 molecule |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CD14 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd3g |
CD3 gamma subunit of T-cell receptor complex |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of CD3G mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 8:45,280,797...45,287,271
Ensembl chr 8:45,281,204...45,287,147
|
|
G |
Cd44 |
CD44 molecule |
multiple interactions increases expression |
ISO |
seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CD44 protein] |
CTD |
PMID:11717450 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd47 |
Cd47 molecule |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CD47 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
|
|
G |
Cd53 |
Cd53 molecule |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CD53 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:194,352,139...194,399,668
Ensembl chr 2:194,352,139...194,399,657
|
|
G |
Cd79a |
CD79a molecule |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CD79A mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:80,493,581...80,497,936
Ensembl chr 1:80,493,581...80,497,935
|
|
G |
Cdh17 |
cadherin 17 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of CDH17 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884
|
|
G |
Cdr2 |
cerebellar degeneration-related protein 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CDR2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:175,502,837...175,527,746
Ensembl chr 1:175,502,838...175,537,472
|
|
G |
Ceacam4 |
CEA cell adhesion molecule 4 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CEACAM10 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:80,376,667...80,382,943
Ensembl chr 1:80,376,648...80,382,915
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CEBPB mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cel |
carboxyl ester lipase |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CEL mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
|
|
G |
Cela2a |
chymotrypsin like elastase 2A |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CELA2A mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 5:154,126,879...154,136,630
Ensembl chr 5:154,126,878...154,136,632
|
|
G |
Ces1d |
carboxylesterase 1D |
increases expression multiple interactions decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CES1 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CES1 mRNA] |
CTD |
PMID:18200517 PMID:19524605 PMID:22609641 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Ces3a |
carboxylesterase 3a |
decreases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of CES3 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CES3 mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cfd |
complement factor D |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of CFD mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Cfh |
complement factor H |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CFH mRNA |
CTD |
PMID:17982090 |
|
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CHI3L1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
|
|
G |
Chkb |
choline kinase beta |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of CHKB mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 7:120,500,960...120,504,359
Ensembl chr 7:120,500,984...120,504,461
|
|
G |
Clca1 |
chloride channel accessory 1 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of CLCA1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
|
|
G |
Clca4 |
chloride channel accessory 4 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CLCA4A mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 2:233,883,625...233,904,993
Ensembl chr 2:233,883,851...233,903,089
|
|
G |
Cldn1 |
claudin 1 |
multiple interactions decreases expression |
ISO |
ginsenoside Re inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CLDN1 protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CLDN1 protein] |
CTD |
PMID:22849695 PMID:39237074 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn2 |
claudin 2 |
multiple interactions decreases expression |
EXP |
oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CLDN2 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CLDN2 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CLDN2 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CLDN2 protein] Trinitrobenzenesulfonic Acid results in decreased expression of CLDN2 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of CLDN2 protein |
CTD |
PMID:35290143 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions increases expression |
ISO |
stattic inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL1A1 mRNA] |
CTD |
PMID:17982090 PMID:25740948 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions increases expression |
ISO |
6-diphenylmethyl-5-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL1A2 mRNA]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL1A2 mRNA]; TACR1 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL1A2 mRNA] |
CTD |
PMID:17982090 PMID:18200517 PMID:20889569 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL4A1 mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL4A2 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL5A1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL5A2 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Cort |
cortistatin |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of CORT protein |
CTD |
PMID:11959675 |
|
NCBI chr 5:159,560,591...159,562,032
|
|
G |
Crh |
corticotropin releasing hormone |
decreases expression increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of CRH mRNA Trinitrobenzenesulfonic Acid results in increased expression of CRH mRNA |
CTD |
PMID:11668029 PMID:11959675 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of CRHR1 mRNA |
CTD |
PMID:15178552 |
|
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
|
|
G |
Crisp3 |
cysteine-rich secretory protein 3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CRISP3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 9:20,432,051...20,472,663
Ensembl chr 9:20,450,908...20,472,658
|
|
G |
Csf2rb |
colony stimulating factor 2 receptor subunit beta |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CSF2RB mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157
|
|
G |
Csf3 |
colony stimulating factor 3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CSF3 protein |
CTD |
PMID:23596210 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions increases expression |
EXP |
geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 mRNA]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 protein] Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 protein |
CTD |
PMID:26165751 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctrl |
chymotrypsin-like |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of CTRB1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr19:33,827,279...33,829,129
Ensembl chr19:33,827,229...33,833,626
|
|
G |
Ctsc |
cathepsin C |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CTSC mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CX3CL1 mRNA |
CTD |
PMID:15973123 |
|
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CXCL10 protein |
CTD |
PMID:23596210 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CXCL12 mRNA |
CTD |
PMID:15973123 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CXCL13 mRNA |
CTD |
PMID:15973123 |
|
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CXCL14 mRNA |
CTD |
PMID:15973123 |
|
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CXCL2 mRNA] |
CTD |
PMID:17375199 PMID:18200517 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions increases expression |
ISO |
icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CXCL1 protein] Trinitrobenzenesulfonic Acid results in increased expression of CXCL1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of CXCL1 protein |
CTD |
PMID:17982090 PMID:23596210 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CXCL9 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of CXCR2 mRNA |
CTD |
PMID:15973123 |
|
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions increases expression |
EXP |
Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CYCS protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CYCS mRNA] Trinitrobenzenesulfonic Acid results in increased expression of CYCS mRNA; Trinitrobenzenesulfonic Acid results in increased expression of CYCS protein |
CTD |
PMID:24831514 PMID:30503585 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP1A2 protein |
CTD |
PMID:18079364 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
multiple interactions |
EXP |
gadolinium chloride inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP2C11 protein]; Polymyxin B inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP2C11 protein]; Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP2C11 protein |
CTD |
PMID:18079364 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP2E1 protein |
CTD |
PMID:18079364 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
gadolinium chloride inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP3A2 protein]; nimesulide inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP3A2 protein]; Polymyxin B inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP3A2 protein]; Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP3A2 protein |
CTD |
PMID:18079364 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of CYP3A13 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Dcp2 |
decapping mRNA 2 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of DCP2 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr18:36,750,732...36,787,067
Ensembl chr18:36,750,732...36,788,557
|
|
G |
Defa5 |
defensin alpha 5 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of DEFA5 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr16:70,342,530...70,344,854
Ensembl chr16:70,342,530...70,344,836
|
|
G |
Defb2 |
defensin beta 2 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of DEFB2 mRNA |
CTD |
PMID:19998380 |
|
NCBI chr16:70,231,870...70,245,817
Ensembl chr16:70,231,945...70,245,784
|
|
G |
Dnaaf5 |
dynein, axonemal, assembly factor 5 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of DNAAF5 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr12:15,453,636...15,492,722
Ensembl chr12:15,453,636...15,492,739
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of DPP4 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dsg2 |
desmoglein 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of DSG2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr18:11,846,207...11,904,630
Ensembl chr18:11,846,183...11,904,156
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of EEF1A1 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of EIF4A2 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of EIF4EBP2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr20:29,379,444...29,400,110
Ensembl chr20:29,382,668...29,399,946
|
|
G |
Emb |
embigin |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of EMB mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
|
|
G |
Ephb3 |
Eph receptor B3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of EPHB3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr11:79,840,668...79,859,345
Ensembl chr11:79,840,668...79,859,370
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of FABP2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:211,040,032...211,044,089
|
|
G |
Faslg |
Fas ligand |
multiple interactions increases expression |
ISO |
D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of FASL protein] Trinitrobenzenesulfonic Acid results in increased expression of FASL protein |
CTD |
PMID:22427801 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fbln2 |
fibulin 2 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of FBLN2 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 4:123,704,289...123,763,857
Ensembl chr 4:123,704,373...123,763,948
|
|
G |
Fbxl2 |
F-box and leucine-rich repeat protein 2 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of FBXL2 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr 8:113,916,660...113,965,137
Ensembl chr 8:113,913,373...113,965,066
|
|
G |
Fcgr2b |
Fc gamma receptor 2B |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of FCGR2B mRNA |
CTD |
PMID:19524605 |
|
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
|
|
G |
Fcgr3a |
Fc gamma receptor 3A |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of FCGR3A mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
|
|
G |
Fgf17 |
fibroblast growth factor 17 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of FGF17 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr15:45,711,498...45,717,622
Ensembl chr15:45,711,998...45,717,063
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of FGFR3 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of FN1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of FOS mRNA |
CTD |
PMID:15178552 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fstl1 |
follistatin-like 1 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of FSTL1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of FXYD5 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
|
|
G |
Gabbr1 |
gamma-aminobutyric acid type B receptor subunit 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of GABBR1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
|
|
G |
Gbp2 |
guanylate binding protein 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of GBP2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gbp4 |
guanylate binding protein 4 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of GBP3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of GCH1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
EXP |
[Trinitrobenzenesulfonic Acid co-treated with Ethanol] results in increased expression of GCLC mRNA |
CTD |
PMID:10830784 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of GCLM mRNA |
CTD |
PMID:22609641 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gda |
guanine deaminase |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of GDA mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
|
|
G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of GDPD3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
|
|
G |
Ggta1 |
glycoprotein alpha-galactosyltransferase 1 |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of GGTA1 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of GGTA1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 3:18,732,985...18,824,916
Ensembl chr 3:18,732,991...18,809,908
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions decreases expression |
EXP |
Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of GOT1 mRNA] |
CTD |
PMID:30503585 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Got1l1 |
glutamic-oxaloacetic transaminase 1-like 1 |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of GOT1L1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr16:64,860,308...64,873,656
Ensembl chr16:64,860,704...64,866,162
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
decreases expression multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of GOT2 mRNA Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of GOT2 mRNA] |
CTD |
PMID:30503585 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of GPX2 mRNA |
CTD |
PMID:31669340 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of GRB10 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806
|
|
G |
Grem1 |
gremlin 1, DAN family BMP antagonist |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of GREM1 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of GREM1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of GRIA2 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases expression multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of GSK3B protein geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of GSK3B protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of GSK3B protein] |
CTD |
PMID:26165751 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsn |
gelsolin |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of GSN mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity multiple interactions decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased activity of GSR protein 4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of GSR protein]; 4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of GSR mRNA] |
CTD |
PMID:31669340 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of GSTM2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of GSTT1 mRNA |
CTD |
PMID:31669340 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
increases expression increases secretion |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of HAVCR1 mRNA Trinitrobenzenesulfonic Acid results in increased secretion of HAVCR1 protein |
CTD |
PMID:23307618 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hbb-b2 |
hemoglobin, beta adult minor chain |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of HBB-B2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:158,243,696...158,245,076
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hebp2 |
heme binding protein 2 |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of HEBP2 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of HEBP2 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 1:13,194,982...13,201,777
Ensembl chr 1:13,194,982...13,201,777
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions increases expression increases abundance |
EXP |
dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of HMGB1 protein]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of HMGB1 protein] 2,4,6-trinitrobenzenesulfonic acid increases abundance of Hmgb1 protein in rat colon |
CTD RGD |
PMID:33412153 PMID:29572553 |
RGD:152995414 |
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of HMGCR mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression decreases expression |
EXP |
dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of HMOX1 protein]; Heme promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of and results in increased activity of HMOX1 protein]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of HMOX1 protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of HMOX1 protein]; Trinitrobenzenesulfonic Acid results in increased expression of and results in increased activity of HMOX1 protein; zinc protoporphyrin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of HMOX1 protein] Trinitrobenzenesulfonic Acid results in increased expression of HMOX1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of HMOX1 protein |
CTD |
PMID:17292349 PMID:25469038 PMID:30503585 PMID:33412153 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hoxd13 |
homeo box D13 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of HOXD13 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 3:59,570,647...59,573,963
Ensembl chr 3:59,570,646...59,573,963
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
affects expression |
EXP |
Trinitrobenzenesulfonic Acid affects the expression of HPGD mRNA |
CTD |
PMID:25526689 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hrh4 |
histamine receptor H4 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of HRH4 mRNA |
CTD |
PMID:24561612 |
|
NCBI chr18:4,166,270...4,182,426
Ensembl chr18:4,166,270...4,246,345
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of HSD11B1 mRNA |
CTD |
PMID:21513799 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of HSPA5 protein Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of HSPA5 protein] |
CTD |
PMID:30503585 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspb7 |
heat shock protein family B (small) member 7 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of HSPB7 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of HTR1A mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of HTR2A mRNA |
CTD |
PMID:23537331 |
|
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions increases expression increases abundance |
ISO EXP |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 mRNA] cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 protein]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 protein]; hesperetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 protein]; Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 mRNA]; Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 protein]; Resveratrol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 mRNA] Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 protein 2,4,6-trinitrobenzenesulfonic acid increases abundance of Icam-1 protein in rat colon |
CTD RGD |
PMID:18200517 PMID:22029500 PMID:26165751 PMID:30503585 PMID:31428839 PMID:33522063 PMID:29572553 More...
|
RGD:152995414 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of IDO1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of IFI27 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
|
|
G |
Ifi30 |
IFI30, lysosomal thiol reductase |
multiple interactions |
EXP |
[topiramate co-treated with Trinitrobenzenesulfonic Acid] results in decreased expression of IFI30 mRNA |
CTD |
PMID:21849664 |
|
NCBI chr16:18,675,590...18,679,655
Ensembl chr16:18,675,613...18,681,175
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of IFIT2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of IFITM3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifnb1 |
interferon beta 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of IFNB1 mRNA |
CTD |
PMID:17375199 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
multiple interactions increases expression decreases expression |
EXP ISO |
bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein] Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA; Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein [cholan-2,3,24-tryl-2,3,24-trisulfate binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein]; [rifaximin binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein]; cholan-2,3,24-tryl-2,3,24-trisulfate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein]; dai-kenchu-to inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG]; Minocycline inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA]; rifaximin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein]; seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA]; sinomenine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA]; sinomenine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein] Trinitrobenzenesulfonic Acid results in increased expression of IFNG; Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA; Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein Trinitrobenzenesulfonic Acid results in decreased expression of IFNG mRNA |
CTD |
PMID:11717450 PMID:15973123 PMID:16782535 PMID:16867261 PMID:19285099 PMID:20136961 PMID:21122500 PMID:21599020 PMID:21829567 PMID:22147983 PMID:23027085 PMID:23537331 PMID:23747339 PMID:24066068 PMID:27783946 PMID:30365937 More...
|
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions increases expression |
ISO EXP |
6-diphenylmethyl-5-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGF1 protein]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGF1 mRNA]; TACR1 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGF1 protein] Trinitrobenzenesulfonic Acid results in increased expression of IGF1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of IGF1 protein |
CTD |
PMID:18200517 PMID:20889569 PMID:24782617 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGFBP4 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGFBP5 mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Il10 |
interleukin 10 |
multiple interactions decreases expression increases expression decreases secretion decreases abundance |
EXP ISO |
[iberogast analog co-treated with Trinitrobenzenesulfonic Acid] results in increased expression of IL10 mRNA; [iberogast co-treated with Trinitrobenzenesulfonic Acid] results in increased expression of IL10 mRNA; bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 mRNA]; dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein]; Isatin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein] [cholan-2,3,24-tryl-2,3,24-trisulfate co-treated with Trinitrobenzenesulfonic Acid] results in increased expression of IL10 protein; [rifaximin co-treated with Trinitrobenzenesulfonic Acid] results in increased expression of IL10 protein; seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 mRNA]; soyasaponin Ab inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein] Trinitrobenzenesulfonic Acid results in decreased expression of IL10; Trinitrobenzenesulfonic Acid results in decreased expression of IL10 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of IL10 protein Trinitrobenzenesulfonic Acid results in increased expression of IL10 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein Trinitrobenzenesulfonic Acid results in decreased secretion of IL10 protein 2,4,6-trinitrobenzenesulfonic acid decreases abundance of IL-10 protein in rat colon |
CTD RGD |
PMID:11717450 PMID:15604057 PMID:15973123 PMID:16867261 PMID:17375199 PMID:19196500 PMID:21599020 PMID:21829567 PMID:22060784 PMID:24316276 PMID:24831514 PMID:25307695 PMID:25727887 PMID:25729217 PMID:30365937 PMID:33412153 PMID:35290143 PMID:29572553 More...
|
RGD:152995414 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of IL12A mRNA |
CTD |
PMID:15973123 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
decreases response to substance multiple interactions increases expression |
ISO EXP |
IL12B protein results in decreased susceptibility to Trinitrobenzenesulfonic Acid Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL12B mRNA]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL12B mRNA] icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL12B protein] Trinitrobenzenesulfonic Acid results in increased expression of IL12B mRNA; Trinitrobenzenesulfonic Acid results in increased expression of IL12B protein |
CTD |
PMID:11782017 PMID:16867261 PMID:17375199 PMID:23596210 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il15 |
interleukin 15 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of IL15 protein |
CTD |
PMID:23596210 |
|
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il17a |
interleukin 17A |
increases expression multiple interactions |
ISO EXP |
Trinitrobenzenesulfonic Acid results in increased expression of IL17A mRNA; Trinitrobenzenesulfonic Acid results in increased expression of IL17A protein [Trinitrobenzenesulfonic Acid results in increased susceptibility to [Ionomycin co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of IL17A protein Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL17A protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL17A protein] |
CTD |
PMID:17375199 PMID:23027085 PMID:27783946 PMID:31428839 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il18 |
interleukin 18 |
increases expression multiple interactions |
ISO EXP |
Trinitrobenzenesulfonic Acid results in increased expression of IL18 mRNA Trinitrobenzenesulfonic Acid results in increased expression of IL18 protein bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL18 protein] |
CTD |
PMID:15973123 PMID:30365937 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of IL1A mRNA Trinitrobenzenesulfonic Acid results in increased expression of IL1A protein icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1A protein] |
CTD |
PMID:12781210 PMID:23596210 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO EXP |
Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]]; Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Huangqin-Tang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; lancemaside A inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; soyasaponin Ab inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; soyasaponin I inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein] 4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; [allicin co-treated with Mesalamine] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; [allicin co-treated with Mesalamine] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; [allicin co-treated with Sulfasalazine] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; [allicin co-treated with Sulfasalazine] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; [Inosine Monophosphate co-treated with potassium oxonate] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Alendronate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; allicin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; allicin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Dinoprostone analog inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; kappa-casein glycomacropeptide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; nitroaspirin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; potassium oxonate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; SC 560 promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; SCH 442416 inhibits the reaction [Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein] Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA; Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein |
CTD |
PMID:15140218 PMID:15604057 PMID:15793857 PMID:15867298 PMID:15973123 PMID:16782535 PMID:16867261 PMID:17375077 PMID:17375199 PMID:17449585 PMID:17982090 PMID:18200517 PMID:19597321 PMID:19956958 PMID:20868668 PMID:20923188 PMID:21513799 PMID:21829567 PMID:21893697 PMID:22039321 PMID:22060784 PMID:22119283 PMID:22609641 PMID:23596210 PMID:23747339 PMID:25079872 PMID:25307695 PMID:25576893 PMID:25727887 PMID:25729217 PMID:26165751 PMID:30365937 PMID:30503585 PMID:35290143 PMID:39237074 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
multiple interactions increases expression |
EXP |
Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1R1 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1R1 mRNA] |
CTD |
PMID:17449585 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of IL1RL1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
multiple interactions increases expression |
EXP |
Alendronate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1RN mRNA]; kappa-casein glycomacropeptide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1RN mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1RN mRNA] |
CTD |
PMID:15867298 PMID:17375077 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il2 |
interleukin 2 |
multiple interactions increases expression |
ISO |
seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL2 mRNA] |
CTD |
PMID:11717450 PMID:27783946 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il23a |
interleukin 23 subunit alpha |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of IL23A mRNA |
CTD |
PMID:17375199 |
|
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Il4 |
interleukin 4 |
increases expression multiple interactions decreases expression decreases secretion |
ISO EXP |
Trinitrobenzenesulfonic Acid results in increased expression of IL4 mRNA [allicin co-treated with Mesalamine] inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased secretion of IL4 protein]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL4 mRNA]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL4 protein]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL4 mRNA]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of IL4 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased secretion of IL4 protein] Trinitrobenzenesulfonic Acid results in decreased expression of IL4 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of IL4 protein |
CTD |
PMID:15973123 PMID:16782535 PMID:16867261 PMID:25729217 PMID:27783946 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression decreases expression |
ISO EXP |
Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]]; Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; Huangqin-Tang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; lancemaside A inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; notoginsenoside R1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; soyasaponin Ab inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; soyasaponin I inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein] Trinitrobenzenesulfonic Acid results in increased expression of IL6; Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; hesperetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; Iridoid Glycosides inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA] Trinitrobenzenesulfonic Acid results in decreased expression of IL6 mRNA |
CTD |
PMID:17375199 PMID:18079364 PMID:18200517 PMID:19956958 PMID:19998380 PMID:20923188 PMID:21070844 PMID:21829567 PMID:22060784 PMID:22410118 PMID:23027085 PMID:23596210 PMID:23747339 PMID:25307695 PMID:25472953 PMID:25576893 PMID:30503585 PMID:31428839 PMID:33522063 PMID:35290143 PMID:39237074 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Insl3 |
insulin-like 3 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of INSL3 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr16:18,398,682...18,400,566
Ensembl chr16:18,384,829...18,400,560
|
|
G |
Irf1 |
interferon regulatory factor 1 |
decreases response to substance |
ISO |
IRF1 protein results in decreased susceptibility to Trinitrobenzenesulfonic Acid |
CTD |
PMID:21097874 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of ISG15 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Itm2a |
integral membrane protein 2A |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ITM2A mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr X:72,486,383...72,492,344
Ensembl chr X:72,486,381...72,492,363
|
|
G |
Itpr2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of ITPR2 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 4:179,028,594...179,434,657
Ensembl chr 4:179,027,281...179,404,164
|
|
G |
Jak2 |
Janus kinase 2 |
increases phosphorylation multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in increased phosphorylation of JAK2 protein cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of JAK2 protein]; hesperetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of JAK2 protein] |
CTD |
PMID:33522063 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of and results in increased phosphorylation of JUN protein]; Trinitrobenzenesulfonic Acid results in increased expression of and results in increased phosphorylation of JUN protein |
CTD |
PMID:22427801 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnab1 |
potassium voltage-gated channel subfamily A regulatory beta subunit 1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of KCNAB1 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 2:149,137,025...149,603,540
Ensembl chr 2:149,137,041...149,603,534
|
|
G |
Kcnj4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of KCNJ4 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 7:111,047,097...111,074,151
Ensembl chr 7:111,047,094...111,074,151
|
|
G |
Kcnq4 |
potassium voltage-gated channel subfamily Q member 4 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of KCNQ4 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 5:134,275,145...134,326,992
Ensembl chr 5:134,275,934...134,326,932
|
|
G |
Kctd9 |
potassium channel tetramerization domain containing 9 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of KCTD9 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr15:41,942,165...41,969,862
Ensembl chr15:41,942,381...41,969,862
|
|
G |
Kitlg |
KIT ligand |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of KITLG mRNA |
CTD |
PMID:17385238 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Kl |
Klotho |
multiple interactions decreases expression |
ISO |
KL protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TRPV5 protein] Trinitrobenzenesulfonic Acid results in decreased expression of KL protein |
CTD |
PMID:23747339 |
|
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
|
|
G |
L1cam |
L1 cell adhesion molecule |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of L1CAM mRNA |
CTD |
PMID:17982090 |
|
NCBI chr X:151,597,270...151,623,776
Ensembl chr X:151,597,277...151,623,857
|
|
G |
Lama3 |
laminin subunit alpha 3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of LAMA3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Lbp |
lipopolysaccharide binding protein |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LBP mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LCN2 mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lcp1 |
lymphocyte cytosolic protein 1 |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of LCP1 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LCP1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
|
|
G |
Lgmn |
legumain |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LGMN mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 6:121,544,048...121,582,495
Ensembl chr 6:121,544,053...121,582,480
|
|
G |
Lilrb4 |
leukocyte immunoglobulin like receptor B4 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of LILRB4 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:69,805,020...69,810,628
Ensembl chr 1:69,805,250...69,810,660
|
|
G |
Lox |
lysyl oxidase |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LOX mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of LRG1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
|
|
G |
Lst1 |
leukocyte specific transcript 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of LST1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr20:3,634,680...3,639,731
Ensembl chr20:3,634,749...3,637,997
|
|
G |
Lum |
lumican |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of LUM mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
|
|
G |
Ly6a |
lymphocyte antigen 6 family member A |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of LY6A mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981
|
|
G |
Ly86 |
lymphocyte antigen 86 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of LY86 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr17:27,415,807...27,499,695
Ensembl chr17:27,415,830...27,487,260
|
|
G |
Lyz2 |
lysozyme 2 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LYZ mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
|
|
G |
Madcam1 |
mucosal vascular addressin cell adhesion molecule 1 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MADCAM1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 7:10,036,301...10,039,703
Ensembl chr 7:10,036,301...10,039,703
|
|
G |
Maf |
MAF bZIP transcription factor |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MAF mRNA; Trinitrobenzenesulfonic Acid results in increased expression of MAF protein sinomenine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MAF mRNA]; sinomenine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MAF protein] |
CTD |
PMID:24066068 |
|
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
|
|
G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MANF mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
|
|
G |
Maoa |
monoamine oxidase A |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of MAOA mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases lipidation |
EXP |
Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:30503585 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of MAP3K6 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212
|
|
G |
Mapk6 |
mitogen-activated protein kinase 6 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of MAPK6 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 8:76,146,650...76,169,767
Ensembl chr 8:76,146,690...76,169,720
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases expression multiple interactions increases phosphorylation |
EXP ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MAPK8 mRNA TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:23537331 PMID:39237074 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions increases expression |
ISO |
[Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein] promotes the reaction [BCL2L11 protein binds to MAPK9 protein]; D-JNKI-1 inhibits the reaction [[Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein] promotes the reaction [BCL2L11 protein binds to MAPK9 protein]]; D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein] |
CTD |
PMID:22427801 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Marcksl1 |
MARCKS-like 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MARCKSL1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of ME1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mgp |
matrix Gla protein |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MGP mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
|
|
G |
Mir155 |
microRNA 155 |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MIR155 mRNA sinomenine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MIR155 mRNA] |
CTD |
PMID:24066068 |
|
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir29a |
microRNA 29a |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MIR29A mRNA |
CTD |
PMID:25277410 |
|
NCBI chr 4:59,650,608...59,650,695
|
|
G |
Mir29b1 |
microRNA 29b-1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MIR29B-1 mRNA |
CTD |
PMID:25277410 |
|
NCBI chr 4:59,650,987...59,651,067
Ensembl chr 4:59,650,986...59,651,067
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MKI67 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions increases expression |
EXP |
ilomastat affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MMP1 protein]; ilomastat inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MMP1 mRNA] Trinitrobenzenesulfonic Acid results in increased expression of MMP1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of MMP1 protein |
CTD |
PMID:18837084 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MMP12 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MMP14 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp15 |
matrix metallopeptidase 15 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MMP15 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MMP2 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein]; Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein]; Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein |
CTD |
PMID:22119283 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mnda |
myeloid cell nuclear differentiation antigen |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of IFI204 mRNA Trinitrobenzenesulfonic Acid results in increased expression of MNDA mRNA |
CTD |
PMID:17982090 |
|
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
|
|
G |
Moxd2 |
monooxygenase, DBH-like 2 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of MOXD2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 4:69,724,693...69,733,188
Ensembl chr 4:69,724,239...69,733,299
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions increases expression increases activity |
EXP ISO |
4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; [potassium oxonate co-treated with Inosine Monophosphate] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Cadmium Chloride inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Ciprofloxacin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Dinoprostone analog inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Genistein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; Heme inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; hesperetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; Indomethacin inhibits the reaction [Smoke promotes the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]]; Indomethacin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Iridoid Glycosides inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Isatin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; montelukast inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; nimesulide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; nitroaspirin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; potassium oxonate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Resveratrol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Rifampin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; SC 560 promotes the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; SCH 442416 inhibits the reaction [Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]]; Smoke promotes the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Spironolactone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; tin protoporphyrin IX promotes the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; zileuton inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; zinc protoporphyrin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein] Trinitrobenzenesulfonic Acid results in increased expression of MPO; Trinitrobenzenesulfonic Acid results in increased expression of MPO protein 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; 8-(bis(2-methylphenyl)methyl)-3-phenyl-8-azabicyclo(3.2.1)octan-3-ol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; [cholan-2,3,24-tryl-2,3,24-trisulfate binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; [Rifaximin binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; cholan-2,3,24-tryl-2,3,24-trisulfate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; ginsenoside Re inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Huangqin-Tang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; J 113397 inhibits the reaction [8-(bis(2-methylphenyl)methyl)-3-phenyl-8-azabicyclo(3.2.1)octan-3-ol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]]; lancemaside A inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; morphiceptin analog affects the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; notoginsenoside R1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Plant Extracts inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; resolvin D1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; resolvin D2 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Rifaximin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; RN 1734 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Ruthenium Red inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; sinomenine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; stattic inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein] 2,4,6-trinitrobenzenesulfonic acid increases myeloperoxidase enzyme activity in rat colon |
CTD RGD |
PMID:10845656 PMID:10877837 PMID:11137876 PMID:11504810 PMID:11668029 PMID:11698051 PMID:11959675 PMID:16474422 PMID:16804969 PMID:16867261 PMID:17276891 PMID:17292349 PMID:17375077 PMID:17375199 PMID:17553498 PMID:17936198 PMID:17991707 PMID:18288370 PMID:19002562 PMID:19234664 PMID:19597321 PMID:19956958 PMID:20868668 PMID:21070844 PMID:21599020 PMID:21724996 PMID:21893697 PMID:22029500 PMID:22039321 PMID:22119283 PMID:22410118 PMID:22849695 PMID:22882778 PMID:23596210 PMID:24038091 PMID:24066068 PMID:24101390 PMID:24316276 PMID:24345466 PMID:24831514 PMID:25079872 PMID:25149976 PMID:25445197 PMID:25472953 PMID:25526689 PMID:25576893 PMID:25740948 PMID:26165751 PMID:30365937 PMID:30503585 PMID:31428839 PMID:31669340 PMID:33412153 PMID:33522063 PMID:29572553 More...
|
RGD:152995414 |
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MRC1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Mrm3 |
mitochondrial rRNA methyltransferase 3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of MRM3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr10:61,095,920...61,125,421
Ensembl chr10:61,095,952...61,102,630
|
|
G |
Mrpl47 |
mitochondrial ribosomal protein L47 |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of MRPL47 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 2:115,507,842...115,520,093
Ensembl chr 2:115,500,264...115,518,994
|
|
G |
Msn |
moesin |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MSN mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases phosphorylation multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in increased phosphorylation of MTOR protein dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of MTOR protein]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of MTOR protein] |
CTD |
PMID:33412153 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Muc17 |
mucin 17, cell surface associated |
increases expression multiple interactions decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of MUC3 mRNA Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MUC3 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MUC3 mRNA] Trinitrobenzenesulfonic Acid results in decreased expression of MUC3 mRNA |
CTD |
PMID:17375077 PMID:17449585 |
|
NCBI chr12:19,527,251...19,536,924
Ensembl chr12:19,527,321...19,538,522
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
multiple interactions increases expression decreases expression |
EXP ISO |
Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MUC2 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MUC2 mRNA] Trinitrobenzenesulfonic Acid results in decreased expression of MUC2 mRNA |
CTD |
PMID:17449585 PMID:19998380 PMID:25307695 |
|
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
|
|
G |
Muc4 |
mucin 4, cell surface associated |
multiple interactions increases expression |
EXP |
Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MUC4 mRNA]; kappa-casein glycomacropeptide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MUC4 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MUC4 mRNA] |
CTD |
PMID:15867298 PMID:17449585 |
|
NCBI chr11:68,008,245...68,053,242
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions increases expression |
EXP |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MYD88 protein]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MYD88 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MYD88 protein] Trinitrobenzenesulfonic Acid results in increased expression of MYD88; Trinitrobenzenesulfonic Acid results in increased expression of MYD88 protein |
CTD |
PMID:16891783 PMID:19002562 PMID:35290143 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Naglu |
N-acetyl-alpha-glucosaminidase |
increases secretion |
EXP |
Trinitrobenzenesulfonic Acid results in increased secretion of NAGLU protein |
CTD |
PMID:23307618 |
|
NCBI chr10:86,001,545...86,009,049
Ensembl chr10:86,001,566...86,008,972
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases expression affects expression |
EXP |
4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NFE2L2 mRNA]; dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid affects the expression of NFE2L2 protein]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid affects the expression of NFE2L2 protein]; Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NFE2L2 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NFE2L2 mRNA] |
CTD |
PMID:31428839 PMID:31669340 PMID:33412153 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
increases expression multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of NFKB1 protein geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NFKB1 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NFKB1 protein] |
CTD |
PMID:26165751 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions increases degradation decreases expression |
EXP |
bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NFKBIA protein]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased degradation of NFKBIA protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased degradation of NFKBIA protein] |
CTD |
PMID:15793857 PMID:30365937 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Ngf |
nerve growth factor |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of NGF mRNA |
CTD |
PMID:17385238 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions increases expression |
EXP |
bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NLRP3 protein] |
CTD |
PMID:30365937 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nmt2 |
N-myristoyltransferase 2 |
decreases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of NMT2 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NMT2 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr17:74,917,833...74,964,788
Ensembl chr17:74,917,833...74,961,080
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
increases expression |
ISO EXP |
Trinitrobenzenesulfonic Acid results in increased expression of NOD2 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of NOD2 protein |
CTD |
PMID:16891783 PMID:22147983 |
|
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression affects response to substance increases activity |
ISO EXP |
Minocycline inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]; NOS2 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCN4 mRNA]; seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]; soyasaponin I inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein] Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein Alendronate affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]; bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein]; Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]; Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]; kappa-casein glycomacropeptide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein]; Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of NOS2 protein]; montelukast inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein]; nitroaspirin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]; Sulfasalazine affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of NOS2 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA] NOS2 protein affects the susceptibility to Trinitrobenzenesulfonic Acid |
CTD |
PMID:10845656 PMID:11504810 PMID:11698051 PMID:11717450 PMID:15867298 PMID:17276891 PMID:17375077 PMID:17449036 PMID:17982090 PMID:19238344 PMID:19285099 PMID:20923188 PMID:21893697 PMID:22039321 PMID:24831514 PMID:30365937 PMID:30503585 PMID:31428839 More...
|
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Npy1r |
neuropeptide Y receptor Y1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of NPY1R mRNA |
CTD |
PMID:23537331 |
|
NCBI chr16:23,037,788...23,047,330
Ensembl chr16:23,037,789...23,046,759
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of NQO1 mRNA |
CTD |
PMID:19524605 PMID:22609641 PMID:25724174 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of NR1H4 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of NR1H4 protein |
CTD |
PMID:21829567 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
decreases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of NR1I2 mRNA [cholan-2,3,24-tryl-2,3,24-trisulfate binds to and results in increased activity of NR1I2 protein] which results in decreased susceptibility to Trinitrobenzenesulfonic Acid; [Rifaximin binds to and results in increased activity of NR1I2 protein] which results in decreased susceptibility to Trinitrobenzenesulfonic Acid [cholan-2,3,24-tryl-2,3,24-trisulfate binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL3 protein]; [cholan-2,3,24-tryl-2,3,24-trisulfate binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein]; [cholan-2,3,24-tryl-2,3,24-trisulfate binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; [cholan-2,3,24-tryl-2,3,24-trisulfate binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; [rifaximin binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL3 protein]; [rifaximin binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein]; [rifaximin binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MPO protein]; [rifaximin binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein] |
CTD |
PMID:21599020 PMID:21829567 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of NR2F1 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 2:8,040,375...8,050,123
Ensembl chr 2:8,040,377...8,050,123
|
|
G |
Nts |
neurotensin |
multiple interactions |
ISO |
NTS protein promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VWF protein] |
CTD |
PMID:25307345 |
|
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
G |
Ntsr1 |
neurotensin receptor 1 |
multiple interactions increases response to substance |
ISO |
NTSR1 protein affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA] NTSR1 protein results in increased susceptibility to Trinitrobenzenesulfonic Acid |
CTD |
PMID:25307345 |
|
NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377
|
|
G |
Nucb2 |
nucleobindin 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of NUCB2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
|
|
G |
Ocln |
occludin |
multiple interactions decreases expression |
ISO EXP |
Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA]; ginsenoside Re inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] |
CTD |
PMID:22147983 PMID:22849695 PMID:25307695 PMID:35290143 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of ODC1 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Oprd1 |
opioid receptor, delta 1 |
multiple interactions increases expression |
EXP |
Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of OPRD1 mRNA]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of OPRD1 protein]; qingre zaoshi liangxue fang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of OPRD1 mRNA]; qingre zaoshi liangxue fang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of OPRD1 protein] Trinitrobenzenesulfonic Acid results in increased expression of OPRD1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of OPRD1 protein |
CTD |
PMID:24637189 |
|
NCBI chr 5:144,306,188...144,340,960
Ensembl chr 5:144,306,188...144,340,960
|
|
G |
Oprl1 |
opioid related nociceptin receptor 1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of OPRL1 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
|
|
G |
Or2h1 |
olfactory receptor family 2 subfamily H member 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of OR2H1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr20:1,445,980...1,446,918
Ensembl chr20:1,444,837...1,449,341
|
|
G |
Or2h2c |
olfactory receptor family 2 subfamily H member 2C |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of OR2H2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr20:1,398,964...1,399,902
Ensembl chr20:1,395,108...1,400,441
|
|
G |
Osmr |
oncostatin M receptor |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of OSMR mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262
|
|
G |
Otud4 |
OTU deubiquitinase 4 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of OTUD4 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr19:28,236,713...28,279,815
Ensembl chr19:28,236,713...28,279,815
|
|
G |
P2rx7 |
purinergic receptor P2X 7 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of P2RX7 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
|
|
G |
P2ry1 |
purinergic receptor P2Y1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of P2RY1 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 2:145,241,975...145,248,186
Ensembl chr 2:145,241,849...145,248,457
|
|
G |
P2ry13 |
purinergic receptor P2Y13 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of P2RY13 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 2:143,470,437...143,476,360
Ensembl chr 2:143,470,425...143,473,434
|
|
G |
Pak2 |
p21 (RAC1) activated kinase 2 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of PAK2 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr11:68,707,940...68,768,816
Ensembl chr11:68,707,969...68,768,816
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of PCK1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of PCNA mRNA; Trinitrobenzenesulfonic Acid results in increased expression of PCNA protein |
CTD |
PMID:19234664 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PDIA3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pdpn |
podoplanin |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PDPN mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
increases expression multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of PECAM1 protein Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PECAM1 protein] |
CTD |
PMID:22410118 |
|
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pgs1 |
phosphatidylglycerophosphate synthase 1 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PGS1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr10:103,214,635...103,250,254
Ensembl chr10:103,214,646...103,250,254
|
|
G |
Pir |
pirin |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PIR mRNA |
CTD |
PMID:19524605 PMID:22609641 |
|
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
|
|
G |
Pirb |
paired Ig-like receptor B |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LILRB3 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 1:65,499,195...65,506,666
Ensembl chr 1:65,499,195...65,506,666
|
|
G |
Pklr |
pyruvate kinase L/R |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PKLR mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pla2g12a |
phospholipase A2, group XIIA |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PLA2G12A mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 2:218,436,497...218,452,742
Ensembl chr 2:218,436,513...218,452,740
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PLA2G2A mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PLA2G7 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
|
|
G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PLOD2 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PLOD2 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
|
|
G |
Pnliprp1 |
pancreatic lipase-related protein 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PNLIPRP1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:257,867,885...257,883,514
Ensembl chr 1:257,867,885...257,883,514
|
|
G |
Pomc |
proopiomelanocortin |
decreases expression increases expression |
ISO EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of POMC mRNA Trinitrobenzenesulfonic Acid results in increased expression of POMC protein |
CTD |
PMID:11959675 PMID:25307695 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions decreases expression |
EXP ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]; geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA] Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein |
CTD |
PMID:16782535 PMID:19617644 PMID:21829567 PMID:24831514 PMID:26165751 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkci |
protein kinase C, iota |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of PRKCI mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 2:112,321,919...112,382,305
Ensembl chr 2:112,321,929...112,382,352
|
|
G |
Prss1 |
serine protease 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PRSS1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of TRY10 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 4:70,364,589...70,367,792
Ensembl chr 4:70,364,586...70,367,792
|
|
G |
Prss3 |
serine protease 3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PRSS3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 4:70,203,088...70,206,562
Ensembl chr 4:70,203,088...70,206,562
|
|
G |
Psme3 |
proteasome activator subunit 3 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PSME3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr10:86,257,672...86,265,458
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of PTGER2 mRNA |
CTD |
PMID:23537331 PMID:25526689 |
|
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of PTGER4 mRNA |
CTD |
PMID:25526689 |
|
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptges |
prostaglandin E synthase |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of PTGES mRNA |
CTD |
PMID:25526689 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptgir |
prostaglandin I2 receptor |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of PTGIR mRNA |
CTD |
PMID:25526689 |
|
NCBI chr 1:77,579,596...77,581,979
Ensembl chr 1:77,579,596...77,581,979
|
|
G |
Ptgis |
prostaglandin I2 synthase |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of PTGIS mRNA |
CTD |
PMID:25526689 |
|
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of PTGS1 mRNA |
CTD |
PMID:25526689 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression decreases expression |
ISO EXP |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; Huangqin-Tang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; lancemaside A inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; soyasaponin I inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein] Alendronate affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; Genistein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; Genistein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; Isatin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2]; nitroaspirin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; Smoke promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; Smoke promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] Trinitrobenzenesulfonic Acid results in increased expression of PTGS2; Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein Trinitrobenzenesulfonic Acid results in decreased expression of PTGS2 mRNA |
CTD |
PMID:11137876 PMID:11698051 PMID:11717450 PMID:11820457 PMID:15973123 PMID:16474422 PMID:16782535 PMID:16804969 PMID:17276891 PMID:17375077 PMID:17375199 PMID:18200517 PMID:19234664 PMID:19956958 PMID:20923188 PMID:21513799 PMID:21893697 PMID:22039321 PMID:24316276 PMID:24831514 PMID:25307695 PMID:25526689 PMID:25576893 PMID:30365937 More...
|
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PTPRC mRNA |
CTD |
PMID:17982090 |
|
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
|
|
G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTPRO mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
|
|
G |
Ptx3 |
pentraxin 3 |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of PTX3 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTX3 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
|
|
G |
Rab10 |
RAB10, member RAS oncogene family |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of RAB10 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 6:26,267,081...26,319,739
Ensembl chr 6:26,266,859...26,320,193
|
|
G |
Rab15 |
RAB15, member RAS oncogene family |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of RAB15 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 6:95,499,584...95,524,073
Ensembl chr 6:95,499,587...95,523,942
|
|
G |
Rab39a |
RAB39A, member RAS oncogene family |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of RAB39A mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 8:54,088,246...54,105,867
Ensembl chr 8:54,088,129...54,106,483
|
|
G |
Rab5a |
RAB5A, member RAS oncogene family |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of RAB5A mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 9:6,483,906...6,512,877
Ensembl chr 9:6,484,469...6,512,873
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of RAMP2 mRNA |
CTD |
PMID:21808981 |
|
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
|
|
G |
Ramp3 |
receptor activity modifying protein 3 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of RAMP3 mRNA |
CTD |
PMID:21808981 |
|
NCBI chr14:81,527,404...81,544,905
Ensembl chr14:81,527,385...81,544,902
|
|
G |
Rap1b |
RAP1B, member of RAS oncogene family |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of RAP1B mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 7:53,423,039...53,456,349
Ensembl chr 7:53,423,130...53,456,370
|
|
G |
Rasa2 |
RAS p21 protein activator 2 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of RASA2 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 8:97,119,983...97,236,687
Ensembl chr 8:97,118,802...97,236,671
|
|
G |
Rasa3 |
RAS p21 protein activator 3 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of RASA3 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr16:75,855,360...75,969,349
Ensembl chr16:75,855,265...75,970,804
|
|
G |
Rasd2 |
RASD family, member 2 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of RASD2 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016
|
|
G |
Rbp1 |
retinol binding protein 1 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RBP1 mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
|
|
G |
Reg3b |
regenerating family member 3 beta |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of REG3A mRNA; Trinitrobenzenesulfonic Acid results in increased expression of REG3B mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of REG3A mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
|
|
G |
Reg3g |
regenerating family member 3 gamma |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of REG3G mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 4:110,922,805...110,927,803
Ensembl chr 4:110,924,168...110,926,723
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions affects localization increases phosphorylation increases expression increases abundance |
EXP ISO |
Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid affects the localization of RELA protein]; dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of RELA protein]; Iridoid Glycosides inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA mRNA]; Iridoid Glycosides inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA protein]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of RELA protein]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of RELA protein]; Resveratrol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of RELA protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA mRNA]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA protein] lancemaside A inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of RELA protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of RELA protein] Trinitrobenzenesulfonic Acid results in increased expression of RELA mRNA; Trinitrobenzenesulfonic Acid results in increased expression of RELA protein 2,4,6-trinitrobenzenesulfonic acid increases abundance of Nf-Kb protein in rat colon |
CTD RGD |
PMID:16474422 PMID:19597321 PMID:19956958 PMID:21070844 PMID:22410118 PMID:24831514 PMID:33412153 PMID:35290143 PMID:29572553 More...
|
RGD:152995414 |
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Retnlb |
resistin like beta |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of RETNLB mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RETNLB mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr11:51,983,482...51,985,368
Ensembl chr11:51,983,483...51,985,368
|
|
G |
Rhoq |
ras homolog family member Q |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of RHOQ mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 6:7,613,632...7,652,047
Ensembl chr 1:106,622,141...106,623,699
|
|
G |
Rmnd1 |
required for meiotic nuclear division 1 homolog |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of RMND1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:40,859,829...40,894,376
Ensembl chr 1:40,859,829...40,894,314
|
|
G |
Rnase1 |
ribonuclease A family member 1, pancreatic |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of RNASE1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr15:24,361,924...24,363,633
Ensembl chr15:24,361,927...24,363,624
|
|
G |
Rngtt |
RNA guanylyltransferase and 5'-phosphatase |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of RNGTT mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 5:47,706,929...47,913,297
Ensembl chr 5:47,706,799...47,913,295
|
|
G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator homolog |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of RPRM mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 3:38,539,581...38,540,998
Ensembl chr 3:38,539,581...38,540,998
|
|
G |
Rreb1 |
ras responsive element binding protein 1 |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of RREB1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr17:26,876,687...27,002,554
Ensembl chr17:26,876,697...27,002,615
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of H2-AA mRNA |
CTD |
PMID:17982090 |
|
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
|
|
G |
RT1-Da |
RT1 class II, locus Da |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of H2-EA mRNA |
CTD |
PMID:17982090 |
|
NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455
|
|
G |
Ryr1 |
ryanodine receptor 1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of RYR1 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of S100A8 mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of S100A9 mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of SAT1 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Scd |
stearoyl-CoA desaturase |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of SCD1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scn10a |
sodium voltage-gated channel alpha subunit 10 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of SCN10A |
CTD |
PMID:15205116 |
|
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
|
|
G |
Selenow |
selenoprotein W |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of SELENOW mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
|
|
G |
Serpinb5 |
serpin family B member 5 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of SERPINB5 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
|
|
G |
Serpine2 |
serpin family E member 2 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SERPINE2 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
|
|
G |
Shbg |
sex hormone binding globulin |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of SHBG mRNA |
CTD |
PMID:17982090 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Sirt1 |
sirtuin 1 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of SIRT1 protein |
CTD |
PMID:24782617 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of SLC10A1 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of SLC10A1 protein |
CTD |
PMID:12044520 |
|
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Slc1a1 |
solute carrier family 1 member 1 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of SLC1A1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
|
|
G |
Slc20a1 |
solute carrier family 20 member 1 |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of SLC20A1 mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
|
|
G |
Slc26a2 |
solute carrier family 26 member 2 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of SLC26A2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr18:54,648,276...54,666,627
Ensembl chr18:54,652,951...54,666,626
|
|
G |
Slc30a10 |
solute carrier family 30, member 10 |
decreases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of SLC30A10 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of SLC30A10 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr13:96,998,143...97,048,076
Ensembl chr13:96,998,143...97,009,103
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of SLC4A4 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of SLCO1A4 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of SLCO1A4 protein |
CTD |
PMID:12044520 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of SLCO1B2 mRNA |
CTD |
PMID:12044520 |
|
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
|
|
G |
Slfn4 |
schlafen family member 4 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of SLFN4 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr10:67,994,601...68,018,141
Ensembl chr10:68,000,028...68,018,138 Ensembl chr10:68,000,028...68,018,138
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SLPI mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G |
Smc2 |
structural maintenance of chromosomes 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of SMC2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242
|
|
G |
Smpx |
small muscle protein, X-linked |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of SMPX mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr X:37,233,209...37,292,266
Ensembl chr X:37,234,294...37,276,708
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
decreases expression multiple interactions increases abundance |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of SOCS3 protein cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of SOCS3 protein]; hesperetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of SOCS3 protein] 2,4,6-trinitrobenzenesulfonic acid increases abundance of Socs3 protein in rat colon |
CTD RGD |
PMID:33522063 PMID:29572553 |
RGD:152995414 |
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA]; Indomethacin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA]; Tretinoin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA] |
CTD |
PMID:17994277 PMID:18200517 |
|
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of SPP1 mRNA Trinitrobenzenesulfonic Acid promotes the reaction [SPP1 protein results in increased susceptibility to Dinitrofluorobenzene] |
CTD |
PMID:14555839 PMID:17982090 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions increases expression |
EXP |
dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SQSTM1 protein]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SQSTM1 protein] |
CTD |
PMID:33412153 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srgn |
serglycin |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of SRGN mRNA |
CTD |
PMID:17982090 |
|
NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
|
|
G |
Srm |
spermidine synthase |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SRM mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of STAT1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases phosphorylation multiple interactions |
ISO EXP |
Trinitrobenzenesulfonic Acid results in increased phosphorylation of STAT3 protein stattic inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of STAT3 protein] bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of STAT3 protein]; cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of STAT3 protein]; hesperetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:25740948 PMID:30365937 PMID:33522063 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stim1 |
stromal interaction molecule 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of STIM1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
|
|
G |
Stk17b |
serine/threonine kinase 17b |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of STK17B mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 9:55,307,485...55,338,085
Ensembl chr 9:55,307,668...55,338,031
|
|
G |
Sulf2 |
sulfatase 2 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SULF2 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415
|
|
G |
Tac1 |
tachykinin, precursor 1 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of TAC1 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Tacr1 |
tachykinin receptor 1 |
multiple interactions affects response to substance |
ISO |
TACR1 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL1A2 mRNA]; TACR1 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGF1 protein]; TACR1 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TGFB1 protein]; TACR1 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VIM mRNA] TACR1 protein affects the susceptibility to Trinitrobenzenesulfonic Acid |
CTD |
PMID:20889569 |
|
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
|
|
G |
Tes |
testin LIM domain protein |
decreases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of TES protein Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]]; Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]]; Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]]; Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]]; Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]]; Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CLDN1 protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:39237074 |
|
NCBI chr 4:45,365,304...45,403,829
Ensembl chr 4:45,365,285...45,403,829
|
|
G |
Tff3 |
trefoil factor 3 |
multiple interactions increases expression |
EXP |
Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TFF3 mRNA]; kappa-casein glycomacropeptide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TFF3 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TFF3 mRNA] |
CTD |
PMID:15867298 PMID:17449585 |
|
NCBI chr20:9,193,259...9,197,969
Ensembl chr20:9,193,262...9,198,054
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions decreases expression increases expression |
ISO |
6-diphenylmethyl-5-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TGFB1 protein]; [rifaximin co-treated with Trinitrobenzenesulfonic Acid] results in increased expression of TGFB1 protein; stattic inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TGFB1 mRNA]; TACR1 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TGFB1 protein] Trinitrobenzenesulfonic Acid results in decreased expression of TGFB1 mRNA Trinitrobenzenesulfonic Acid results in increased expression of TGFB1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of TGFB1 protein |
CTD |
PMID:20889569 PMID:21599020 PMID:25307695 PMID:25740948 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of TGFB2 mRNA |
CTD |
PMID:25307695 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of TGFBR1 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Tgm2 |
transglutaminase 2 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TGM2 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
|
|
G |
Tgm3 |
transglutaminase 3 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of TGM3 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 3:117,228,661...117,264,078
Ensembl chr 3:117,228,661...117,264,075
|
|
G |
Thbd |
thrombomodulin |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of THBD mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
|
|
G |
Thbs1 |
thrombospondin 1 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of THBS1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
increases expression multiple interactions |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of THY1 mRNA Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of THY1 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions increases expression |
ISO EXP |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TIMP1 mRNA] ilomastat affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TIMP1 mRNA]; ilomastat affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TIMP1 protein] Trinitrobenzenesulfonic Acid results in increased expression of TIMP1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of TIMP1 protein |
CTD |
PMID:17982090 PMID:18200517 PMID:18837084 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions decreases expression |
ISO EXP |
ginsenoside Re inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein] Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein] |
CTD |
PMID:22147983 PMID:22849695 PMID:35290143 PMID:39237074 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tjp2 |
tight junction protein 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of TJP2 mRNA |
CTD |
PMID:25307695 |
|
NCBI chr 1:221,709,745...221,838,291
Ensembl chr 1:221,709,745...221,838,295
|
|
G |
Tlr2 |
toll-like receptor 2 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of TLR2 |
CTD |
PMID:16891783 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions increases expression decreases expression |
ISO EXP |
lancemaside A inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TLR4 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TLR4 protein] Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TLR4 protein] Trinitrobenzenesulfonic Acid results in increased expression of TLR4; Trinitrobenzenesulfonic Acid results in increased expression of TLR4 protein Trinitrobenzenesulfonic Acid results in decreased expression of TLR4 mRNA |
CTD |
PMID:16891783 PMID:19002562 PMID:19597321 PMID:19956958 PMID:19998380 PMID:20136961 More...
|
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr9 |
toll-like receptor 9 |
multiple interactions increases expression |
EXP |
oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TLR9 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TLR9 protein] |
CTD |
PMID:35290143 |
|
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tmem245 |
transmembrane protein 245 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of TMEM245 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr 5:71,570,952...71,647,915
Ensembl chr 5:71,514,858...71,647,763
|
|
G |
Tmt1a |
thiol methyltransferase 1A |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TMT1A mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 7:131,452,099...131,460,154
Ensembl chr 7:131,451,641...131,460,154
|
|
G |
Tnc |
tenascin C |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNC mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression increases secretion increases abundance |
ISO EXP |
[cholan-2,3,24-tryl-2,3,24-trisulfate binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; [Rifaximin binds to and results in increased activity of NR1I2 protein] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]]; Anisomycin inhibits the reaction [TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]]; cholan-2,3,24-tryl-2,3,24-trisulfate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; dai-kenchu-to inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF]; Huangqin-Tang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; lancemaside A inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Minocycline inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; notoginsenoside R1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Rifaximin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; sinomenine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; sinomenine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; soyasaponin Ab inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; soyasaponin I inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein] 4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; [allicin co-treated with Mesalamine] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; [allicin co-treated with Sulfasalazine] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; [Inosine Monophosphate co-treated with potassium oxonate] inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased secretion of TNF protein]; allicin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Dinoprostone analog inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; hesperetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; iberogast inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Iridoid Glycosides inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Isatin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF]; Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; nitroaspirin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; potassium oxonate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Resveratrol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; SC 560 promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; SCH 442416 inhibits the reaction [Inosine Monophosphate inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased secretion of TNF protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein] Trinitrobenzenesulfonic Acid results in increased expression of TNF; Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA; Trinitrobenzenesulfonic Acid results in increased expression of TNF protein 2,4,6-trinitrobenzenesulfonic acid increases abundance of Tnfa protein in rat colon |
CTD RGD |
PMID:11717450 PMID:12717850 PMID:16474422 PMID:16782535 PMID:16867261 PMID:17276891 PMID:17375199 PMID:17449585 PMID:18200517 PMID:19196500 PMID:19285099 PMID:19597321 PMID:19956958 PMID:19998380 PMID:20136961 PMID:20868668 PMID:20923188 PMID:21070844 PMID:21122500 PMID:21513799 PMID:21599020 PMID:21829567 PMID:21893697 PMID:22039321 PMID:22060784 PMID:22119283 PMID:22147983 PMID:22410118 PMID:22427801 PMID:23027085 PMID:23537331 PMID:23596210 PMID:23747339 PMID:24066068 PMID:24316276 PMID:24831514 PMID:25472953 PMID:25576893 PMID:25727887 PMID:25729217 PMID:27783946 PMID:30503585 PMID:33412153 PMID:33522063 PMID:35290143 PMID:39237074 PMID:29572553 More...
|
RGD:152995414 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf25 |
TNF receptor superfamily member 25 |
increases response to substance |
ISO |
TNFRSF25 protein results in increased susceptibility to Trinitrobenzenesulfonic Acid |
CTD |
PMID:20980995 |
|
NCBI chr 5:162,621,669...162,626,341
Ensembl chr 5:162,622,075...162,626,341
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of TNFSF11 protein |
CTD |
PMID:23747339 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tnfsf15 |
TNF superfamily member 15 |
increases response to substance |
ISO |
TNFSF15 protein results in increased susceptibility to Trinitrobenzenesulfonic Acid |
CTD |
PMID:20980995 |
|
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
|
|
G |
Tnfsf4 |
TNF superfamily member 4 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of TNFSF4 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr13:73,723,329...73,746,809
Ensembl chr13:73,723,329...73,746,788
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO EXP |
D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of TRP53 protein] Trinitrobenzenesulfonic Acid results in increased expression of TRP53 protein Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of and results in increased activity of TP53 protein]; Trinitrobenzenesulfonic Acid results in increased phosphorylation of and results in increased activity of TP53 protein |
CTD |
PMID:22427801 PMID:30503585 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trim15 |
tripartite motif containing 15 |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TRIM15 mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr20:1,700,905...1,710,249
Ensembl chr20:1,700,905...1,710,249
|
|
G |
Trim16 |
tripartite motif-containing 16 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of TRIM16 mRNA |
CTD |
PMID:19524605 PMID:22609641 |
|
NCBI chr10:47,485,982...47,509,010
Ensembl chr10:47,486,297...47,551,907
|
|
G |
Trip4 |
thyroid hormone receptor interactor 4 |
increases expression multiple interactions |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of TRIP4 protein bergenin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TRIP4 protein] |
CTD |
PMID:30365937 |
|
NCBI chr 8:66,351,861...66,439,679
Ensembl chr 8:66,353,248...66,439,774
|
|
G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of TRPC3 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855
|
|
G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of TRPM8 mRNA |
CTD |
PMID:23596210 |
|
NCBI chr 9:88,897,039...88,990,167
Ensembl chr 9:88,903,880...88,988,552
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions decreases expression increases expression |
EXP |
topiramate inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TRPV1 mRNA] Trinitrobenzenesulfonic Acid results in increased expression of TRPV1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of TRPV1 protein |
CTD |
PMID:17698068 PMID:17991707 PMID:21849664 PMID:25445197 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of TRPV4 mRNA |
CTD |
PMID:22882778 |
|
NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517
|
|
G |
Trpv5 |
transient receptor potential cation channel, subfamily V, member 5 |
multiple interactions |
ISO |
KL protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TRPV5 protein]; Trinitrobenzenesulfonic Acid results in decreased expression of and results in increased metabolism of TRPV5 protein |
CTD |
PMID:23747339 |
|
NCBI chr 4:70,536,432...70,562,743
Ensembl chr 4:70,536,440...70,562,745
|
|
G |
Txndc16 |
thioredoxin domain containing 16 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of TXNDC16 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr15:18,351,688...18,425,833
Ensembl chr15:18,351,694...18,425,722
|
|
G |
Tyrobp |
transmembrane immune signaling adaptor Tyrobp |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TYROBP mRNA] |
CTD |
PMID:17982090 PMID:18200517 |
|
NCBI chr 1:85,672,931...85,676,856
Ensembl chr 1:85,672,994...85,676,848
|
|
G |
Ubc |
ubiquitin C |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of UBC mRNA |
CTD |
PMID:12163651 |
|
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
|
|
G |
Ubd |
ubiquitin D |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of UBD mRNA |
CTD |
PMID:17982090 |
|
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
|
|
G |
Ube2w |
ubiquitin-conjugating enzyme E2W |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of UBE2W mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 5:2,690,742...2,754,491
Ensembl chr 5:2,690,763...2,814,965
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of UGT1A6 mRNA |
CTD |
PMID:12163651 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Usp8 |
ubiquitin specific peptidase 8 |
decreases expression |
EXP |
Trinitrobenzenesulfonic Acid results in decreased expression of USP8 mRNA |
CTD |
PMID:23537331 |
|
NCBI chr 3:113,962,136...114,009,683
Ensembl chr 3:113,962,164...114,009,666
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
increases expression multiple interactions |
ISO EXP |
Trinitrobenzenesulfonic Acid results in increased expression of VCAM1 mRNA Trinitrobenzenesulfonic Acid results in increased expression of VCAM1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of VCAM1 protein Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VCAM1 mRNA]; Resveratrol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VCAM1 protein]; Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VCAM1 mRNA] |
CTD |
PMID:17982090 PMID:22029500 PMID:30503585 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vcan |
versican |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VCAN mRNA] |
CTD |
PMID:18200517 |
|
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression |
EXP ISO |
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA]]; Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA]; Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA] NTSR1 protein affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA] |
CTD |
PMID:21893697 PMID:25307345 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
multiple interactions increases expression |
ISO |
6-diphenylmethyl-5-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VIM mRNA]; TACR1 gene mutant form inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VIM mRNA] |
CTD |
PMID:20889569 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vnn1 |
vanin 1 |
increases expression |
EXP |
Trinitrobenzenesulfonic Acid results in increased expression of VNN1 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of VNN1 protein |
CTD |
PMID:23307618 |
|
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
|
|
G |
Vwf |
von Willebrand factor |
multiple interactions increases expression |
ISO |
NTS protein promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VWF protein] |
CTD |
PMID:25307345 |
|
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
|
|
G |
Wdr48 |
WD repeat domain 48 |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of WDR48 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 8:119,622,053...119,655,264
Ensembl chr 8:119,622,048...119,655,264
|
|
G |
Wfdc18 |
WAP four-disulfide core domain 18 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of WFDC18 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr10:68,588,818...68,590,972
Ensembl chr10:68,588,818...68,589,671
|
|
G |
Zc3h11a |
zinc finger CCCH-type containing 11A |
decreases expression |
ISO |
Trinitrobenzenesulfonic Acid results in decreased expression of ZC3H11A mRNA |
CTD |
PMID:17982090 |
|
NCBI chr13:45,073,422...45,113,901
Ensembl chr13:45,071,718...45,114,009
|
|
G |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
increases expression |
ISO |
Trinitrobenzenesulfonic Acid results in increased expression of ZFP36L2 mRNA |
CTD |
PMID:17982090 |
|
NCBI chr 6:10,490,032...10,494,073
Ensembl chr 6:10,490,032...10,494,064
|
|